YU

Yasuo Urata

President & CEO

Oncolys BioPharma Inc.

Tokyo


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Oncolys BioPharma Inc.
Industry
research
Employees
26.0
Seniority
C suite
Annual Revenue
7121000.0

Technologies

Outlook Mobile Friendly YouTube Google Tag Manager Google Font API Apache Micro

Keywords

oncology oncolytic viral therapy orphan drugs emerging infectious diseases biotechnology research oncolytic adenovirus cancer treatment drug discovery diagnostic services scientific innovation pipeline development therapeutic options gene modification clinical trials immunotherapy pharmaceutical development infectious diseases prognostic tests early detection loco-regional therapy novel drugs tumorigenesis cancer immuno-reactions drug licensing medical science advancement patient care pharmaceutical business virology-based technology genetic engineering precision medicine biotechnology healthcare solutions clinical research next generation therapies cancer diagnostics companion diagnostics patient-centric solutions r&d strategy drug efficacy cancer vaccines tailored treatments pharmacovigilance investor relations stock information investor presentations scientific publications corporate philosophy healthcare innovation unmet medical needs biopharmaceuticals therapeutic candidates research & development hospital & health care health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans